Daniel Anggono is a seasoned market access professional with extensive experience in both industry and strategy consulting. They have held leadership roles at Pfizer and Sanofi, focusing on oncology and autoimmune treatments across global payer systems in mature and emerging markets. Currently, Daniel is pursuing a BSE in Bioengineering at the University of Pennsylvania. Their expertise spans a broad disease portfolio and they have successfully led access strategies for various therapies, including IBRANCE and Tzield.
This person is not in any teams
This person is not in any offices